![Detlef F. Albrecht](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Detlef F. Albrecht
Technik-/Wissenschafts-/F&E-Leiter bei
SATSUMA PHARMACEUTICALS, INC.
Profil
Detlef F.
Albrecht was the founder of Relypsa, Inc. founded in 2007, where he held the title of Chief Medical Officer & SVP-Research & Development.
Currently, he is the Chief Medical Officer at Satsuma Pharmaceuticals, Inc. since 2017.
Dr. Albrecht's former positions include President, Chief Executive Officer & Director at Sorbent Therapeutics, Inc., Senior Director-Clinical Development at Miravant Medical Technologies, Director-Clinical Development at Schwarz Pharma, Inc., Vice President-Clinical Development at ALZA Corp., Chief Medical Officer & Senior Vice President at IntraBiotics Pharmaceuticals, Inc., Chief Medical Officer, SVP-Research & Development at Ilypsa, Inc., and Chief Medical Officer & Head-Drug Development at Armetheon, Inc. Dr. Albrecht holds a doctorate degree from RWTH Aachen University.
Aktive Positionen von Detlef F. Albrecht
| Unternehmen | Position | Beginn |
|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2017 |
Ehemalige bekannte Positionen von Detlef F. Albrecht
| Unternehmen | Position | Ende |
|---|---|---|
Armetheon, Inc.
 Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2009 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Technik-/Wissenschafts-/F&E-Leiter | 22.01.2007 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.01.2004 |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Detlef F. Albrecht
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Miravant Medical Technologies
 Miravant Medical Technologies Pharmaceuticals: MajorHealth Technology Develops light activated drugs and associated devices for photodynamic therapy | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Health Technology |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Health Technology |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company for migraine and debilitating conditions | Health Technology |
Wählen Sie MarketScreener 
